MINXRAY, INC. – Trademark Portfolio

Entity Type: 03

MINXRAY, INC. holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 1 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include MINXRAY and X-RANGER. The owner is based in NORTHBROOK, IL.

3611 COMMERCIAL AVENUE

NORTHBROOK, IL 60062

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

X-RANGER
X-RANGER
Registered 2025
MINXRAY
MINXRAY
Registered 1973

Trademark Classifications

MINXRAY, INC.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

9
Computers & Electronics (1 filing)

Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does MINXRAY, INC. have?

MINXRAY, INC. has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.

What trademark classes does MINXRAY, INC. file in?

MINXRAY, INC. files trademarks across 2 Nice Classification classes. The most active classes are Class 9 (Computers & Electronics), Class 10 (Medical Apparatus). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.

What are MINXRAY, INC.'s most well-known trademarks?

MINXRAY, INC.'s registered trademark portfolio includes well-known marks such as MINXRAY and X-RANGER. These are among 2 currently registered trademarks in the portfolio.

What is MINXRAY, INC.'s trademark registration success rate?

MINXRAY, INC. has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.